TY  - JOUR
A1  - Bohlken, Jens
A1  - Weber, Simon A.
A1  - Siebert, Anke
A1  - Forstmeier, Simon
A1  - Kohlmann, Thomas
A1  - Rapp, Michael A.
T1  - Reminiscence therapy for depression in dementia
BT  - An observational study with matched pairs
JF  - GeroPsych - The Journal of gerontopsychology and geriatric psychiatry
N2  - We investigated the efficacy of reminiscence therapy (RT) on symptoms of depression in patients with mild to moderate dementia. Out of 227 patients with mild to moderate dementia from a specialized physician’s office, 27 pairs (N = 54; mean age 79.04 ± 6.16 years) who had either received treatment as usual (TAU) or TAU combined with RT, were matched retrospectively according to age as well as cognitive and depressive symptom scores. After controlling for age and sex, symptoms of depression significantly decreased over time in the RT group compared to TAU (F1,52 = 4.36; p < .05). RT is a promising option for the treatment of depression in mild to moderate dementia. Larger randomized-controlled trials are needed.
KW  - reminiscence
KW  - life story book
Y1  - 2017
U6  - https://doi.org/10.1024/1662-9647/a000175
SN  - 1662-9647
SN  - 1662-971X
VL  - 30
SP  - 145
EP  - 151
PB  - Hogrefe
CY  - Göttingen
ER  - 
TY  - BOOK
A1  - Mientus, Lukas
A1  - Klempin, Christiane
A1  - Nowak, Anna
A1  - Wyss, Corinne
A1  - Aufschnaiter, Claudia von
A1  - Faix, Ann-Christin
A1  - te Poel, Kathrin
A1  - Wahbe, Nadia
A1  - Pieper, Martin
A1  - Höller, Katharina
A1  - Kallenbach, Lea
A1  - Förster, Magdalena
A1  - Redecker, Anke
A1  - Dick, Mirjam
A1  - Holle, Jörg
A1  - Schneider, Edina
A1  - Rehfeldt, Daniel
A1  - Brauns, Sarah
A1  - Abels, Simone
A1  - Ferencik-Lehmkuhl, Daria
A1  - Fränkel, Silvia
A1  - Frohn, Julia
A1  - Liebsch, Ann-Catherine
A1  - Pech, Detlef
A1  - Schreier, Pascal
A1  - Jessen, Moiken
A1  - Großmann, Uta
A1  - Skintey, Lesya
A1  - Voerkel, Paul
A1  - Vaz Ferreira, Mergenfel A.
A1  - Zimmermann, Jan-Simon
A1  - Buddeberg, Magdalena
A1  - Henke, Vanessa
A1  - Hornberg, Sabine
A1  - Völschow, Yvette
A1  - Warrelmann, Julia-Nadine
A1  - Malek, Jennifer
A1  - Tinnefeld, Anja
A1  - Schmidt, Peggy
A1  - Bauer, Tobias
A1  - Jänisch, Christopher
A1  - Spitzer, Lisa
A1  - Franken, Nadine
A1  - Degeling, Maria
A1  - Preisfeld, Angelika
A1  - Meier, Jana
A1  - Küth, Simon
A1  - Scholl, Daniel
A1  - Vogelsang, Christoph
A1  - Watson, Christina
A1  - Weißbach, Anna
A1  - Kulgemeyer, Christoph
A1  - Oetken, Mandy
A1  - Gorski, Sebastian
A1  - Kubsch, Marcus
A1  - Sorge, Stefan
A1  - Wulff, Peter
A1  - Fellenz, Carolin D.
A1  - Schnell, Susanne
A1  - Larisch, Cathleen
A1  - Kaiser, Franz
A1  - Knott, Christina
A1  - Reimer, Stefanie
A1  - Stegmüller, Nathalie
A1  - Boukrayâa Trabelsi, Kathrin
A1  - Schißlbauer, Franziska
A1  - Lemberger, Lukas
A1  - Barth, Ulrike
A1  - Wiehl, Angelika
A1  - Rogge, Tim
A1  - Böhnke, Anja
A1  - Dietz, Dennis
A1  - Großmann, Leroy
A1  - Wienmeister, Annett
A1  - Zoppke, Till
A1  - Jiang, Lisa
A1  - Grünbauer, Stephanie
A1  - Ostersehlt, Dörte
A1  - Peukert, Sophia
A1  - Schäfer, Christoph
A1  - Löbig, Anna
A1  - Bröll, Leena
A1  - Brandt, Birgit
A1  - Breuer, Meike
A1  - Dausend, Henriette
A1  - Krelle, Michael
A1  - Andersen, Gesine
A1  - Falke, Sascha
A1  - Kindermann-Güzel, Kristin
A1  - Körner, Katrina
A1  - Lottermoser, Lisa-Marie
A1  - Pügner, Kati
A1  - Sonnenburg, Nadine
A1  - Akarsu, Selim
A1  - Rechl, Friederike
A1  - Gadinger, Laureen
A1  - Heinze, Lena
A1  - Wittmann, Eveline
A1  - Franke, Manuela
A1  - Lachmund, Anne-Marie
A1  - Böttger, Julia
A1  - Hannover, Bettina
A1  - Behrendt, Renata
A1  - Conty, Valentina
A1  - Grundmann, Stephanie
A1  - Ghassemi, Novid
A1  - Opitz, Ben
A1  - Brämer, Martin
A1  - Gasparjan, David
A1  - Sambanis, Michaela
A1  - Köster, Hilde
A1  - Lücke, Martin
A1  - Nordmeier, Volkhard
A1  - Schaal, Sonja
A1  - Haberbosch, Maximilian
A1  - Meissner, Maren
A1  - Schaal, Steffen
A1  - Brüchner, Melanie
A1  - Riehle, Tamara
A1  - Leopold, Bengta Marie
A1  - Gerlach, Susanne
A1  - Rau-Patschke, Sarah
A1  - Skorsetz, Nina
A1  - Weber, Nadine
A1  - Damköhler, Jens
A1  - Elsholz, Markus
A1  - Trefzger, Thomas
A1  - Lewek, Tobias
A1  - Borowski, Andreas
ED  - Mientus, Lukas
ED  - Klempin, Christiane
ED  - Nowak, Anna
T1  - Reflexion in der Lehrkräftebildung
BT  - Empirisch – Phasenübergreifend – Interdisziplinär
T3  - Potsdamer Beiträge für Lehrkräftebildung und Bildungsforschung
N2  - Reflexion ist eine Schlüsselkategorie für die professionelle Entwicklung von Lehrkräften, welche als Ausbildungsziel in den Bildungsstandards für die Lehrkräftebildung verankert ist. Eine Verstetigung universitär geprägter Forschung und Modellierung in der praxisnahen Anwendung im schulischen Kontext bietet Potentiale nachhaltiger Professionalisierung. Die Stärkung reflexionsbezogener Kompetenzen durch Empirie und Anwendung scheint eine phasenübergreifende Herausforderung der Lehrkräftebildung zu sein, die es zu bewältigen gilt. Ziele des Tagungsbandes Reflexion in der Lehrkräftebildung sind eine theoretische Schärfung des Konzeptes „Reflexive Professionalisierung“ und der Austausch über Fragen der Einbettung wirksamer reflexionsbezogener Lerngelegenheiten in die Lehrkräftebildung. Forschende und Lehrende der‚ drei Phasen (Studium, Referendariat sowie Fort- und Weiterbildung) der Lehrkräftebildung stellen Lehrkonzepte und Forschungsprojekte zum Thema Reflexion in der Lehrkräftebildung vor und diskutieren diese. Gemeinsam mit Teilnehmenden aller Phasen und von verschiedenen Standorten der Lehrkräftebildung werden zukünftige Herausforderungen identifiziert und Lösungsansätze herausgearbeitet.
T3  - Potsdamer Beiträge zur Lehrkräftebildung und Bildungsforschung - 4 
KW  - Reflexion
KW  - Lehrkräftebildung
KW  - Reflexionskompetenz
KW  - Reflexivität
KW  - Feedback
KW  - Reflection
KW  - Teacher Education
KW  - Reflection Skills
KW  - Reflexivity
KW  - Feedback
Y1  - 2023
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-591717
SN  - 978-3-86956-566-8
SN  - 2626-3556
SN  - 2626-4722
IS  - 4
PB  - Universitätsverlag Potsdam
CY  - Potsdam
ER  - 
TY  - GEN
A1  - Bohlken, Jens
A1  - Weber, Simon
A1  - Rapp, Michael A.
A1  - Kostev, Karel
T1  - Continuous treatment with antidementia drugs in Germany 2003–2013
BT  - a retrospective database analysis
T2  - Postprints der Universität Potsdam : Humanwissenschaftliche Reihe
N2  - Background: Continuous treatment is an important indicator of medication adherence in dementia. However, long-term studies in larger clinical settings are lacking, and little is known about moderating effects of patient and service characteristics.

Methods: Data from 12,910 outpatients with dementia (mean age 79.2 years; SD = 7.6 years) treated between January 2003 and December 2013 in Germany were included. Continuous treatment was analysed using Kaplan-Meier curves and log-rank tests. In addition, multivariate Cox regression models were fitted with continuous treatment as dependent variable and the predictors antidementia agent, age, gender, medical comorbidities, physician specialty, and health insurance status.

Results: After one year of follow-up, nearly 60% of patients continued drug treatment. Donezepil (HR: 0.88; 95% CI: 0.82-0.95) and memantine (HR: 0.85; 0.79-0.91) patients were less likely to be discontinued treatment as compared to rivastigmine users. Patients were less likely to be discontinued if they were treated by specialist physicians as compared to general practitioners (HR: 0.44; 0.41-0.48). Younger male patients and patients who had private health insurance had a lower discontinuation risk. Regarding comorbidity, patients were more likely to be continuously treated with the index substance if a diagnosis of heart failure or hypertension had been diagnosed at baseline.

Conclusions: Our results imply that besides type of antidementia agent, involvement of a specialist in the complex process of prescribing antidementia drugs can provide meaningful benefits to patients, in terms of more disease-specific and continuous treatment.
T3  - Zweitveröffentlichungen der Universität Potsdam : Humanwissenschaftliche Reihe - 522 
KW  - Alzheimer’s disease
KW  - dementia
KW  - treatment continuation
KW  - persistence
KW  - adherence
KW  - cholinesterase inhibitors
KW  - memantine
Y1  - 2019
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-414718
SN  - 1866-8364
IS  - 522
ER  - 
TY  - JOUR
A1  - Bohlken, Jens
A1  - Weber, Simon
A1  - Rapp, Michael A.
A1  - Kostev, Karel
T1  - Continuous treatment with antidementia drugs in Germany 2003-2013: a retrospective database analysis
JF  - International psychogeriatrics
N2  - Background: Continuous treatment is an important indicator of medication adherence in dementia. However, long-term studies in larger clinical settings are lacking, and little is known about moderating effects of patient and service characteristics.
 Methods: Data from 12,910 outpatients with dementia (mean age 79.2 years; SD = 7.6 years) treated between January 2003 and December 2013 in Germany were included. Continuous treatment was analysed using Kaplan-Meier curves and log-rank tests. In addition, multivariate Cox regression models were fitted with continuous treatment as dependent variable and the predictors antidementia agent, age, gender, medical comorbidities, physician specialty, and health insurance status.
 Results: After one year of follow-up, nearly 60% of patients continued drug treatment. Donezepil (HR: 0.88; 95% CI: 0.82-0.95) and memantine (HR: 0.85; 0.79-0.91) patients were less likely to be discontinued treatment as compared to rivastigmine users. Patients were less likely to be discontinued if they were treated by specialist physicians as compared to general practitioners (HR: 0.44; 0.41-0.48). Younger male patients and patients who had private health insurance had a lower discontinuation risk. Regarding comorbidity, patients were more likely to be continuously treated with the index substance if a diagnosis of heart failure or hypertension had been diagnosed at baseline.
 Conclusions: Our results imply that besides type of antidementia agent, involvement of a specialist in the complex process of prescribing antidementia drugs can provide meaningful benefits to patients, in terms of more disease-specific and continuous treatment.
KW  - adherence
KW  - cholinesterase inhibitors
KW  - memantine
Y1  - 2015
U6  - https://doi.org/10.1017/S1041610215000654
SN  - 1041-6102
SN  - 1741-203X
VL  - 27
IS  - 8
SP  - 1335
EP  - 1342
PB  - Cambridge Univ. Press
CY  - New York
ER  -